{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:26:27Z","timestamp":1790011587659,"version":"4.0.1"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Gansu Provincial University Teachers' Innovation Fund"},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["25JRRA931"],"award-info":[{"award-number":["25JRRA931"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177822","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T18:53:50Z","timestamp":1749236030000},"page":"177822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The liver-gut axis perspective: Exploring the pathogenesis of fatty liver"],"prefix":"10.1016","volume":"1002","author":[{"given":"Zonghui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177822_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/liv.14453","article-title":"Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"40","author":"Adams","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2025.177822_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.05.003","article-title":"Evaluation of the gut barrier to intestinal bacteria in non-alcoholic fatty liver disease","volume":"55","author":"Andrea","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hep.24611","article-title":"Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development","volume":"54","author":"Anna","year":"2011","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.177822_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib9","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/hep.29760","article-title":"Gut-liver axis alterations in alcoholic liver disease: are bile acids the answer?","volume":"67","author":"Bajaj","year":"2018","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jgr.2014.04.002","article-title":"Effects of Korean red ginseng (panax ginseng), urushiol (rhus vernicifera stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut-liver axis of alcoholic liver disease","volume":"38","author":"Bang","year":"2014","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.ejphar.2025.177822_bib11","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1053\/j.gastro.2022.01.058","article-title":"Nonalcoholic fatty liver disease and the gut-liver axis: exploring an undernutrition perspective","volume":"162","author":"Bauer","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.177822_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/nu12040951","article-title":"Oral supplementation of sodium butyrate attenuates the progression of non-alcoholic steatohepatitis","volume":"12","author":"Baumann","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2025.177822_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177822_bib14","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1074\/jbc.M808818200","article-title":"Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis","volume":"284","author":"Bhatnagar","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177822_bib15","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically healthy obesity","volume":"41","author":"Bl\u00fcher","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2025.177822_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0140-6736(02)99258-5","article-title":"Observations on the minute anatomy of fatty degeneration of the liver","volume":"37","author":"Bowman","year":"1842","journal-title":"The Lancet"},{"key":"10.1016\/j.ejphar.2025.177822_bib17","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.3390\/molecules24152776","article-title":"Identification of patulin from as a toxin for enteric neurons","volume":"24","author":"Brand","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.ejphar.2025.177822_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.177822_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121565","article-title":"Structural elucidation of an active polysaccharide from Radix puerariae lobatae and its protection against acute alcoholic liver disease","volume":"325","author":"Cao","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejphar.2025.177822_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115146","article-title":"Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity","volume":"292","author":"Cao","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2025.177822_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177822_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jep.2017.03.003","article-title":"Effects of antrosterol from Antrodia camphorata submerged whole broth on lipid homeostasis, antioxidation, alcohol clearance, and anti-inflammation in livers of chronic-alcohol fed mice","volume":"202","author":"Chang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2025.177822_bib24","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.177822_bib25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3390\/microorganisms11051181","article-title":"The novel role of phage particles in chronic liver diseases","volume":"11","author":"Chen","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejphar.2025.177822_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.947382","article-title":"The gut microbiota: a novel player in autoimmune hepatitis","volume":"12","author":"Cheng","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib29","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41467-022-28478-3","article-title":"IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence","volume":"13","author":"Chiang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177822_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ejphar.2025.177822_bib31","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.177822_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1186\/s12967-024-05709-3","article-title":"Influence of the gut microbiota on immune cell interactions and cancer treatment","volume":"22","author":"Chunxiao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.177822_bib33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Claudia","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2468-1253(16)30241-2","article-title":"The intestinal microbiome and paediatric liver disease","volume":"2","author":"Daniel","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and Obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Demir","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177822_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jn\/nxy324","article-title":"Supplementation with sodium butyrate modulates the composition of the gut microbiota and ameliorates high-fat diet-induced obesity in mice","volume":"149","author":"Fang","year":"2019","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2025.177822_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03263-19","article-title":"Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease","volume":"11","author":"Fei","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ejphar.2025.177822_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.dld.2012.11.010","article-title":"Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies","volume":"45","author":"Frasinariu","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejphar.2025.177822_bib42","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1984122","article-title":"Gut non-bacterial microbiota contributing to alcohol-associated liver disease","volume":"13","author":"Gao","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2025.177822_bib43","doi-asserted-by":"crossref","first-page":"25250","DOI":"10.1073\/pnas.1911189116","article-title":"Distinct metabolic adaptation of liver circadian pathways to acute and chronic patterns of alcohol intake","volume":"116","author":"Gaucher","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2025.177822_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Akkermansia muciniphilaRecovery of ethanol-induced depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2025.177822_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Gy\u00f6rgy","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Harrison","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Harshad","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib48","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00351-17","article-title":"High-fat diet changes fungal microbiomes and interkingdom relationships in the murine gut","volume":"2","author":"Heisel","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.ejphar.2025.177822_bib50","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic Obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.177822_bib51","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jhep.2021.08.003","article-title":"Intestinal virome and therapeutic potential of bacteriophages in liver disease","volume":"75","author":"Hsu","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib52","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3390\/ijms24044240","article-title":"YTHDF1 attenuates TBI-induced brain-gut axis dysfunction in mice","volume":"24","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177822_bib53","article-title":"The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease","volume":"16","author":"Hui","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2025.177822_bib54","first-page":"183","article-title":"Lactobacillus plantarum KLDS1.0344 and Lactobacillus acidophilus KLDS1.0901 mixture prevents chronic alcoholic liver injury in mice by protecting the intestinal barrier and regulating gut microbiota and liver-related pathways","volume":"69","author":"Huizhen","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2025.177822_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177822_bib56","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/j.2040-4603.2022.tb00205.x","article-title":"Bile acids, gut microbiome and the road to fatty liver disease","volume":"12","author":"Hylemon","year":"2021","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib57","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2025.177822_bib58","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/CM9.0000000000002156","article-title":"Bile acids and sphingolipids in non-alcoholic fatty liver disease","volume":"135","author":"Jackson","year":"2022","journal-title":"Chin Med J."},{"key":"10.1016\/j.ejphar.2025.177822_bib59","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature14851","article-title":"Decompensated cirrhosis and microbiome interpretation","volume":"525","author":"Jasmohan","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177822_bib60","first-page":"13","article-title":"Interaction between gut microbiota and toll-like receptor: from immunity to metabolism","volume":"95","author":"Jensen","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177822_bib61","first-page":"131","article-title":"Melatonin alleviates high temperature exposure induced fetal growth restriction via the gut-placenta-fetus axis in pregnant mice","volume":"68","author":"Jia-Jin","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2025.177822_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hbpd.2018.11.002","article-title":"Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis","volume":"18","author":"Jiang","year":"2019","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.ejphar.2025.177822_bib64","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib65","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.32608","article-title":"Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation","volume":"77","author":"Jiang","year":"2023","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.redox.2014.09.004","article-title":"Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling","volume":"3","author":"J\u00f6rn M","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2025.177822_bib67","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation?","volume":"14","author":"Josephine","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib68","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J Physiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib71","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177822_bib72","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","article-title":"Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis","volume":"35","author":"Kuang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177822_bib73","article-title":"Association between gut microbiota and prediabetes in people living with HIV","volume":"3","author":"Kulapong","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.ejphar.2025.177822_bib74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-immunol-051116-052424","article-title":"Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing","volume":"35","author":"Kurashima","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.177822_bib75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejphar.2025.177822_bib76","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3350\/cmh.2020.0125","article-title":"Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis","volume":"27","author":"Lee","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib77","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages","volume":"73","author":"Lefere","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib78","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2022.01.017","article-title":"Mucosal fungi promote gut barrier function and social behavior via type 17 immunity","volume":"185","author":"Leonardi","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177822_bib79","first-page":"12","article-title":"Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats","volume":"9","author":"Li","year":"2022","journal-title":"Mil Med. Res."},{"key":"10.1016\/j.ejphar.2025.177822_bib80","article-title":"Heterogeneity and function of kupffer cells in liver injury","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177822_bib82","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177822_bib83","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Marc-Emmanuel","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2025.177822_bib84","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1139\/y98-049","article-title":"The gut as a potential trigger of exercise-induced inflammatory responses","volume":"76","author":"Marshall","year":"1998","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177822_bib85","first-page":"9","article-title":"The intestinal epithelial barrier: a therapeutic target?","volume":"14","author":"Matthew A","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib86","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177822_bib87","article-title":"Role of microbiota-derived short-chain fatty acids in cancer development and prevention","volume":"139","author":"Mirzaei","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177822_bib88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/5584_2018_314","article-title":"Can postbiotics represent a new strategy for NEC?","volume":"1125","author":"Mosca","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2025.177822_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.908011","article-title":"The role of gut microbiota-bile acids axis in the progression of non-alcoholic fatty liver disease","volume":"13","author":"Ni","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib90","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.dld.2012.11.010","article-title":"Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies","volume":"45","author":"Otilia E","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejphar.2025.177822_bib91","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut-liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib92","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/ijms23010426","article-title":"Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases","volume":"23","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177822_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174841","article-title":"Inonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR\/SHP\/SREBP-1c axis","volume":"921","author":"Peng","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177822_bib94","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0036-1593882","article-title":"Bidirectional communication between liver and gut during alcoholic liver disease","volume":"36","author":"Peter","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2025.177822_bib95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib96","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2009.03.007","article-title":"Signalling pathways in alcohol-induced liver inflammation","volume":"50","author":"Pranoti","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib97","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.3390\/nu13124203","article-title":"The effects of butyrate on induced metabolic-associated fatty liver disease in precision-cut liver slices","volume":"13","author":"Prins","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2025.177822_bib98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2018.04.005","article-title":"Bile acid regulation: a novel therapeutic strategy in non-alcoholic fatty liver disease","volume":"190","author":"Qinwei","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.177822_bib99","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cmet.2023.03.013","article-title":"DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman Primates","volume":"35","author":"Qu","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177822_bib100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41586-021-03241-8","article-title":"Multi-kingdom ecological drivers of microbiota assembly in preterm infants","volume":"591","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177822_bib101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrgastro.2015.15","article-title":"NAFLD. Leaky guts: intestinal permeability and NASH","volume":"12","author":"Ray","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib102","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrgastro.2017.152","article-title":"Alcoholic liver disease: gut-Liver axis: ppis, enterococcus and promotion of alcoholic liver disease","volume":"14","author":"Ray","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib103","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC - Mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib104","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2025.177822_bib106","article-title":"Toll-like receptors and metabolic (Dysfunction)-associated fatty liver disease","volume":"185","author":"Shaghayegh","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177822_bib107","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s42003-021-02753-3","article-title":"The gut commensal fungus, Candida parapsilosis, promotes high fat-diet induced obesity in mice","volume":"4","author":"Shanshan","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejphar.2025.177822_bib108","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2020.11.010","article-title":"Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease","volume":"33","author":"Sharpton","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177822_bib109","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.ejphar.2025.177822_bib110","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib111","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.cgh.2022.11.030","article-title":"Blood endotoxin levels as biomarker of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Soppert","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib112","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177822_bib113","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri.2017.100","article-title":"Organ-specific protection mediated by cooperation between vascular and epithelial barriers","volume":"17","author":"Spadoni","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.177822_bib114","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1830693","article-title":"Wolfiporia cocosTherapeutic manipulation of gut microbiota by polysaccharides of reveals the contribution of the gut fungi-induced PGE to alcoholic hepatic steatosis","volume":"12","author":"Sun","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2025.177822_bib115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.177822_bib116","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3748\/wjg.v16.i11.1321","article-title":"Alcoholic liver disease and the gut-liver axis","volume":"16","author":"Szabo","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.177822_bib117","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1159\/000324281","article-title":"Gut-liver axis and sensing microbes","volume":"28","author":"Szabo","year":"2010","journal-title":"Dig. Dis."},{"key":"10.1016\/j.ejphar.2025.177822_bib118","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-023-06466-x","article-title":"Gut microbial carbohydrate metabolism contributes to insulin resistance","volume":"621","author":"Takeuchi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177822_bib119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/112_2018_10","article-title":"Targeting oxidative stress for the treatment of liver fibrosis","volume":"175","author":"Theerut","year":"2018","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177822_bib120","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177822_bib121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.177822_bib122","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2025.177822_bib123","doi-asserted-by":"crossref","DOI":"10.1093\/cdn\/nzz145","article-title":"Time of feeding alters obesity-associated parameters and gut bacterial communities, but not fungal populations, in C57BL\/6 Male mice","volume":"4","author":"van der Merwe","year":"2020","journal-title":"Curr. Dev. Nutr."},{"key":"10.1016\/j.ejphar.2025.177822_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.703218","article-title":"The role of short-chain fatty acids and bile acids in intestinal and liver function, inflammation, and carcinogenesis","volume":"9","author":"Visekruna","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.177822_bib125","article-title":"Altered fecal microbiota correlates with liver biochemistry in Nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177822_bib126","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000200","article-title":"Experimental models of fatty liver diseases: status and appraisal","volume":"7","author":"Wang","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2025.177822_bib129","article-title":"Tolypocladium sinenseDietary supplementation with mycelium prevents dyslipidemia inflammation in high fat diet mice by modulation of gut microbiota in mice","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177822_bib130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177822_bib131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biochi.2015.05.014","article-title":"Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice","volume":"115","author":"Wei-Bin","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.ejphar.2025.177822_bib128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2025.177822_bib127","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2025.177822_bib132","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","article-title":"Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid","volume":"8","author":"Wei","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib133","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40168-021-01024-x","article-title":"Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities","volume":"9","author":"Wu","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.ejphar.2025.177822_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.756486","article-title":"Aythya baeriGut microbial alterations in diarrheal baer's pochards","volume":"8","author":"Xi","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.ejphar.2025.177822_bib135","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1039\/C9FO03015H","article-title":"Vinegar extract ameliorates alcohol-induced liver damage associated with the modulation ofgut microbiota in mice","volume":"11","author":"Xia","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2025.177822_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1199519","article-title":"Activation of kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions","volume":"11","author":"Xu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.177822_bib137","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/hep.32577","article-title":"Hepatocellular cystathionine \u03b3 lyase\/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor","volume":"76","author":"Xu","year":"2022","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib138","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177822_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib140","article-title":"Effect of fucoidan on ethanol-induced liver injury and steatosis in mice and the underlying mechanism","volume":"65","author":"Xue","year":"2021","journal-title":"Food Nutr. Res., Suppl."},{"key":"10.1016\/j.ejphar.2025.177822_bib141","first-page":"70","article-title":"Cyclic nucleotide phosphodiesterases in alcohol use disorders: involving gut microbiota","volume":"26","author":"Xueqin","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2025.177822_bib142","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan","year":"2011","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib143","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1021\/acs.jafc.1c02362","article-title":"Dietary ursolic acid prevents alcohol-induced liver injury via gut-liver axis homeostasis modulation: the key role of microbiome manipulation","volume":"69","author":"Yan","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2025.177822_bib144","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Yong-Han","year":"2003","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.634","article-title":"Lactobacillus lactis and pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease","volume":"11","author":"Yu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.177822_bib146","article-title":"Polysaccharide from aerial part of Chuanminshen violaceum alleviates oxidative stress and inflammatory response in aging mice through modulating intestinal microbiota","volume":"14","author":"Yuan-Feng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177822_bib147","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Zahra","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2025.177822_bib148","article-title":"New insights into the pathogenesis of alcoholic liver disease based on global research","author":"Zhang","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2025.177822_bib149","article-title":"Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12967-023-03940-y","article-title":"Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.177822_bib151","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2025.177822_bib152","article-title":"Intestinal Candida albicans promotes hepatocarcinogenesis by Up-Regulating NLRP6","volume":"13","author":"Zherui","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2025.177822_bib153","first-page":"1","article-title":"Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression","volume":"50","author":"Zhou","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177822_bib154","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology (Baltim., Md.)"},{"key":"10.1016\/j.ejphar.2025.177822_bib155","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.apsb.2016.07.008","article-title":"Fatty liver diseases, bile acids, and FXR","volume":"6","author":"Zhu","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2025.177822_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115923","article-title":"Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg\/Th1 cells","volume":"439","author":"Zhu","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500576X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500576X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:25:22Z","timestamp":1778876722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992500576X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":154,"alternative-id":["S001429992500576X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177822","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The liver-gut axis perspective: Exploring the pathogenesis of fatty liver","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177822"}}